Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,159 | -28,684 | -20,595 | -927 | -23,953 |
| Depreciation Amortization | 1,379 | 1,080 | 723 | 367 | 1,469 |
| Accounts receivable | 2,621 | -1,026 | 1,446 | 1,799 | -1,850 |
| Other Working Capital | 2,933 | 931 | 615 | 819 | -2,825 |
| Other Operating Activity | 9,426 | 19,956 | 11,806 | -3,673 | 14,819 |
| Operating Cash Flow | $-8,800 | $-7,743 | $-6,005 | $-1,615 | $-12,340 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 111 | 113 | 114 | -3 | -11 |
| PPE Investments | -931 | -276 | -142 | -37 | -369 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -11 |
| Purchase Sale Intangibles | -1,063 | -751 | -555 | -259 | -848 |
| Other Investing Activity | -1,063 | -751 | -555 | -259 | -848 |
| Investing Cash Flow | $-1,883 | $-914 | $-583 | $-299 | $-1,239 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -74 | -49 | -37 | -19 | -113 |
| Common Stock Issued | 47,840 | 47,782 | 15,513 | 15,464 | 81 |
| Other Financing Activity | 0 | 0 | -43 | 0 | 0 |
| Financing Cash Flow | $47,766 | $47,733 | $15,433 | $15,445 | $-32 |
| Beginning Cash Position | 11,192 | 11,192 | 11,192 | 11,192 | 24,803 |
| End Cash Position | 48,275 | 50,268 | 20,037 | 24,723 | 11,192 |
| Net Cash Flow | $37,083 | $39,076 | $8,845 | $13,531 | $-13,611 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,800 | -7,743 | -6,005 | -1,615 | -12,340 |
| Capital Expenditure | -931 | -276 | -142 | -37 | -369 |
| Free Cash Flow | -9,731 | -8,019 | -6,147 | -1,652 | -12,709 |